Athira Pharma, Inc.
USD6.75
-0.44 (-6.12%)
CEO
Mark J. Litton
IPO Date
2020-09-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.30
Prev. Close
$7.19
Day Low
$6.61
Day High
$7.35
52W Low
$2.20
52W High
$8.36
Market Cap
$0.03B
Volume
0.07M
| 1,644 |
| $6.88 |
| 5 Jan 2026 | San Martin Javier | CHIEF MEDICAL OFFICER | M-Exempt | Disposed | 4,667 | $0.00 |
| 5 Jan 2026 | Litton Mark James | director, officer: President and CEO | M-Exempt | Acquired | 10,834 | $0.00 |
| 5 Jan 2026 | Litton Mark James | director, officer: President and CEO | S-Sale | Disposed | 2,586 | $6.88 |
| 5 Jan 2026 | Litton Mark James | director, officer: President and CEO | M-Exempt | Disposed | 10,834 | $0.00 |
| 5 Jan 2026 | Renninger Robert | Chief Financial Officer | A-Award | Acquired | 1,000 | $2.31 |
| 5 Jan 2026 | Renninger Robert | Chief Financial Officer | M-Exempt | Acquired | 1,236 | $0.00 |
| 5 Jan 2026 | Renninger Robert | Chief Financial Officer | S-Sale | Disposed | 297 | $6.88 |
| 5 Jan 2026 | Renninger Robert | Chief Financial Officer | M-Exempt | Disposed | 1,236 | $0.00 |